1998
DOI: 10.1002/(sici)1097-4652(199802)174:2<251::aid-jcp12>3.0.co;2-f
|View full text |Cite
|
Sign up to set email alerts
|

Role of epidermal growth factor in the acquisition of ovarian steroid hormone responsiveness in the normal mouse mammary gland

Abstract: The purpose of the present studies was to investigate the role of epidermal growth factor (EGF) in the acquisition of estrogen (E) and progestin (P) responsiveness in the mouse mammary gland in vivo. Using the Elvax 40P implant technique to introduce bioactive molecules directly into the mammary gland to produce a localized effect, we have made the novel observation that EGF implanted into glands of pubertal mice followed by E treatment resulted in the precocious acquisition of E-inducible progesterone recepto… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
19
0
1

Year Published

2000
2000
2008
2008

Publication Types

Select...
7
3

Relationship

1
9

Authors

Journals

citations
Cited by 45 publications
(22 citation statements)
references
References 30 publications
2
19
0
1
Order By: Relevance
“…Epidermal growth factor (EGF), in addition to promoting the proliferation of terminal end-buds, augments estrogen-induced ductal outgrowth and progesterone-induced sidebranching [23]. Indeed, estrogen induces PR isoform expression only in the presence of EGF [24], suggesting the existence of important cross-talk between EGFRs and both SRs. Ligand-activated PRs and ERs are potent breast mitogens, and mammary epithelial cells that express PR also express ERα.…”
Section: Pr and Signaling Cross-talk In Breast Cancersupporting
confidence: 61%
“…Epidermal growth factor (EGF), in addition to promoting the proliferation of terminal end-buds, augments estrogen-induced ductal outgrowth and progesterone-induced sidebranching [23]. Indeed, estrogen induces PR isoform expression only in the presence of EGF [24], suggesting the existence of important cross-talk between EGFRs and both SRs. Ligand-activated PRs and ERs are potent breast mitogens, and mammary epithelial cells that express PR also express ERα.…”
Section: Pr and Signaling Cross-talk In Breast Cancersupporting
confidence: 61%
“…Several signaling systems have been implicated as potential mediators of the effects of estrogen. These include the epidermal growth factor (EGF) family of ligands and receptors (Ankrapp et al 1998, Sebastian et al 1998, Luetteke et al 1999, Weisen et al 1999, insulin-like growth factor-1 (Kleinberg et al 2000) and hepatocyte growth factor/scatter factor (Yang et al 1995). In addition, transforming growth factor (TGF)-has been shown to be a potent inhibitor of end bud proliferation and ductal growth (Daniel et al 1989, Robinson et al 1991, Pierce et al 1993.…”
Section: Discussionmentioning
confidence: 99%
“…For example, administration of the anti-estrogen ICI 182780 reduces the response to EGF in the mammary gland (Ankrapp et al 1998). Studies in ERa-knockout mice demonstrated that EGF could not induce DNA synthesis in the uterus even in the presence of wildtype levels of EGF and EGFR (Curtis et al 1996, Ankrapp et al 1998.…”
Section: Role Of the Igf-1r And Egfr In E2 Rapid Actionmentioning
confidence: 99%